When compared to all control groups consisting of basal insulin (glargine or degludec), selective GLP1-RA (dulaglutide or semaglutide once weekly), and placebo, an increased risk of pancreatitis was not found to be significantly associated with tirzepatide (RR 1.46, [95% CI] 0.59 to 3.61
Applications can be smaller and more portable
Most people tolerate it well, but some may experience mild digestive shifts when they first start
Contact your healthcare provider promptly if you develop jaundice (yellowing of skin or eyes), dark-colored urine, pale stools, persistent right upper quadrant abdominal pain, or unexplained severe fatigue
These tools increase accountability and help you identify patterns that influence your progress
DeFronzo RA, Fleck PR, Wilson CA, et al